Purpose Neuroendocrine tumors (NETs) are considered rare tumors and can produce a
variety of hormones. In this study, we examined the epidemiology of and prognostic factors …

Neuroendocrine tumors (NETs) constitute a heterogeneous group of neoplasms that
originate from endocrine glands such as the pituitary, the parathyroids, and the …

Background Patients with advanced midgut neuroendocrine tumors who have had disease
progression during first-line somatostatin analogue therapy have limited therapeutic options …

Abstract Serotonin (5‐hydroxytryptamine, HT), a neurotransmitter, and its main metabolite 5‐
hydroxyindole‐3‐acetic acid (HIAA) are biomarkers for carcinoid tumors. They can be …

Background There have been few epidemiological studies on gastroenteropancreatic
neuroendocrine tumors (GEP-NETs) in Japan. Methods We examined the epidemiology of …

Objective Neuroendocrine tumors of the gynecologic tract are rare, and pose a significant
clinical challenge because of the tumor heterogeneity and lack of standardized guidelines …

Neuroendocrine tumours account for only 0.5% of all malignancies. The incidence is
approximately 2/100,000 with a female preponderance under the age of 50 years due to …

With the recent approval of 177Lu-DOTATATE for use in gastroenteropancreatic
neuroendocrine tumors, access to peptide receptor radionuclide therapy is increasing …

Neuroendocrine tumours (NET) of the gastroenteropancreatic system comprise a malignant
entity with a low incidence. Only limited information is available on long-term clinical …

BACKGROUND Carcinoids are rare indolent neuroendocrine tumors, mainly located in
bowel, stomach, and lung. Their etiology is virtually unknown although a family history is a …